Last €5.08 EUR
Change Today +0.02 / 0.40%
Volume 10.4K
EOSI On Other Exchanges
Symbol
Exchange
EN Paris
OTC US
As of 11:35 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

eos imaging sa (EOSI) Snapshot

Open
€5.08
Previous Close
€5.06
Day High
€5.12
Day Low
€5.08
52 Week High
02/13/14 - €8.36
52 Week Low
10/16/14 - €4.46
Market Cap
93.4M
Average Volume 10 Days
26.6K
EPS TTM
--
Shares Outstanding
18.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EOS IMAGING SA (EOSI)

Related News

No related news articles were found.

eos imaging sa (EOSI) Related Businessweek News

No Related Businessweek News Found

eos imaging sa (EOSI) Details

EOS Imaging SA designs, develops, and markets patented medical imaging systems used for the treatment of osteo-articular conditions. The company offers a 3D surgical planning service and patient-specific cutting guides for orthopaedic surgeries, as well as sterEOS, an associated review workstation. It also develops and markets patient-specific orthopaedic solutions for hip and knee arthroplasties, which enable surgeons to have cutting guides customized to the anatomy of patient in the operating room. EOS Imaging SA operates in France, EMEA region, North America, and Asia. The company was formerly known as biospace med and changed its name to EOS Imaging SA in 2010. EOS Imaging SA was founded in 1989 and is headquartered in Paris, France.

101 Employees
Last Reported Date: 03/31/14
Founded in 1989

eos imaging sa (EOSI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: €240.1K
Vice President of Marketing
Total Annual Compensation: €112.0K
Compensation as of Fiscal Year 2013.

eos imaging sa (EOSI) Key Developments

EOS Imaging Announces Adoption of the EOS Imaging System at the University Children's Hospital Zurich

EOS imaging announced continued adoption of the EOS imaging system in Switzerland with an installation at the University Children's Hospital Zurich (UCHZ). The installation at UCHZ is the company's fifth installation in the country. The EOS(R) system provides full-body images of patients in a natural functional position in both 2D and 3D with 50% to 85% less dose than digital radiology and 95% less dose than basic CT scans, in accordance with the ALARA (As Low As Reasonably Achievable) principle of radiation reduction.

EOS imaging Obtains Marketing Approval in South Korea

EOS imaging announced that the company has received approval from the Korean Food and Drug Administration (KFDA) to market the EOS(R) system in South Korea, further expanding the Company's commercial opportunities in the fast growing Asia Pacific market. The Company has now obtained authorization to market its technology in 34 countries. Approval to market the EOS system in South Korea follows similar regional authorizations in Japan and Taiwan and represents a significant milestone as the region continues to adopt EOS' technology for orthopedic imaging. The KFDA approval will enable the Company to continue expanding its presence in the Asia Pacific medical imaging market, which is predicted to see the highest growth globally during the next 5 years.

EOS Imaging Reports Unaudited Consolidated Revenue Results Third Quarter and the First Nine Months Ended September 30, 2014

EOS imaging reported unaudited consolidated revenue results third quarter and the first nine months ended September 30, 2014. For the nine months, the company reported total revenue of EUR 11.06 million against EUR 7.69 million a year ago. For the quarter, the company reported total revenue of EUR 3.94 million against EUR 2.78 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EOSI:FP €5.08 EUR +0.02

EOSI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EOSI.
View Industry Companies
 

Industry Analysis

EOSI

Industry Average

Valuation EOSI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.5x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EOS IMAGING SA, please visit www.eos-imaging.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.